Cargando…
Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
Synthetic cannabinoids (SCs) induce a pro-inflammatory condition by activating cannabinoid receptor 1 (CB(1)R) in the lungs of mice, which raises a potential therapeutic use of CB(1)R antagonists in SC-induced lung disease resulting in hospitalisation https://bit.ly/31bWw4Q
Autores principales: | Zawatsky, Charles N., Abdalla, Jasmina, Cinar, Resat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430153/ https://www.ncbi.nlm.nih.gov/pubmed/32832534 http://dx.doi.org/10.1183/23120541.00121-2020 |
Ejemplares similares
-
Synthetic cannabinoids and renal injury
por: Alp, Alper
Publicado: (2015) -
Functional Selectivity of a Biased Cannabinoid-1
Receptor (CB(1)R) Antagonist
por: Liu, Ziyi, et al.
Publicado: (2021) -
Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014) -
Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023) -
Cholesterol as a modulator of cannabinoid receptor CB(2) signaling
por: Yeliseev, Alexei, et al.
Publicado: (2021)